Low-dose gemcitabine plus nab-paclitaxel versus standard-dose gemcitabine plus nab-paclitaxel in elderly patients with metastatic pancreatic cancer: A randomized Phase II trial.
Kamata K, Imai H, Matsumoto H, Yamashita Y, Kato T, Nishi K, Omoto S, Minaga K, Yamao K, Hyodo T, Im SW, Hara A, Yoshikawa T, Ishikawa R, Okamoto A, Yamazaki T, Nakai A, Ueshima K, Chiba Y, Takenaka M, Watanabe T, Kitano M, Kudo M.
Kamata K, et al. Among authors: kudo m.
JGH Open. 2023 Sep 7;7(9):659-666. doi: 10.1002/jgh3.12966. eCollection 2023 Sep.
JGH Open. 2023.
PMID: 37744711
Free PMC article.